Related references
Note: Only part of the references are listed.Diverse facets of MDSC in different phases of chronic HBV infection: Impact on HBV-specific T-cell response and homing
Sourina Pal et al.
HEPATOLOGY (2022)
Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics
Jian Gao et al.
ACTA PHARMACEUTICA SINICA B (2022)
Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-? signaling in regulatory T cells
Jian Gu et al.
CELL REPORTS (2022)
Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor
Na Qu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
Zhendong Song et al.
ACTA PHARMACEUTICA SINICA B (2021)
Triptolide decreases tumor-associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor-derived CXCL12
Xuan Jiang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment
Shuling Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment
Mauro Di Pilato et al.
CELL (2021)
Advances and challenges of mesenchymal stem cells for pregnancy-related diseases COMMENT
Yan-Hong Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Methionine enkephalin activates autophagy and stimulates tumour cell immunogenicity in human cutaneous squamous cell carcinoma
Xueli Bai et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Methionine enkephalin (MENK) suppresses lung cancer by regulating the Bcl-2/Bax/caspase-3 signaling pathway and enhancing natural killer cell-driven tumor immunity
Shuling Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell
Binglin Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
Yuyin Fu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation
Xiaozheng Chen et al.
THERANOSTICS (2021)
An update on the use of immunotherapy in patients with colorectal cancer
Mike Nguyen et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy
Michael A. Morse et al.
ONCOLOGIST (2020)
Renal and brain complications in GLA p.Phe113Leu Fabry disease. Comments on Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males by Oliveira et al. (Eur. J. Med. Genet. 2019)
Alexandra Smirnova et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2020)
PD-1/PD-L1-dependent immune response in colorectal cancer
Zahra Payandeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice
Yali Tuo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Targeting SHP2 as a promising strategy for cancer immunotherapy
Qianqian Liu et al.
PHARMACOLOGICAL RESEARCH (2020)
Andrographolide potentiates PD-1 blockade immunotherapy by inhibiting COX2-mediated PGE2 release
Wen Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Cell-cell contact with proinflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models
Yanhong Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis
Chen Wei et al.
MOLECULAR CANCER (2019)
CD30 ligand deficiency accelerates glioma progression by promoting the formation of tumor immune microenvironment
Jin Duan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
Mingxia Zhao et al.
ACTA PHARMACEUTICA SINICA B (2019)
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer
Margaret L. Axelrod et al.
CLINICAL CANCER RESEARCH (2019)
Comparison of Western and Asian Guidelines Concerning the Management of Colon Cancer
Gianluca Pellino et al.
DISEASES OF THE COLON & RECTUM (2018)
Novel effect of methionine enkephalin against influenza A virus infection through inhibiting TLR7-MyD88-TRAF6-NF-kappa B p65 signaling pathway
Jing Tian et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Margaretha G. M. Roemer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
Scott J. Rodig et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Methionine enkephalin (MENK) inhibits human gastric cancer through regulating tumor associated macrophages (TAMs) and PI3K/AKT/mTOR signaling pathway inside cancer cells
Xiaonan Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Rules to activate CD8(+)T cells through regulating subunits of opioid receptors by methionine enkephalin (MENK)
Xue Jiao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Catalpol suppressed proliferation, growth and invasion of CT26 colon cancer by inhibiting inflammation and tumor angiogenesis
Pingting Zhu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
Douglas B. Johnson et al.
NATURE COMMUNICATIONS (2016)
Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes
Andres Forero et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Methionine Enkephalin (MENK) Inhibits tumor growth through regulating CD4+Foxp3+Regulatory T cells (Tregs) in mice
Xuan Li et al.
CANCER BIOLOGY & THERAPY (2015)
Myeloid-Derived Suppressor Cells: Paradoxical Roles in Infection and Immunity
Jun Dai et al.
JOURNAL OF INNATE IMMUNITY (2015)
Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK)
Weiwei Li et al.
CANCER LETTERS (2014)
Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs)
Qiushi Wang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
The Gastrointestinal Tumor Microenvironment
Michael Quante et al.
GASTROENTEROLOGY (2013)
Cancer-Related Inflammation
Juliana Candido et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses
Wenna Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models
Hiroko Oshima et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Comparison of stimulating effect on subpopulations of lymphocytes in human peripheral blood by methionine enkephalin with IL-2 and IFN-γ
Hui Hua et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Methionine enkephalin (MENK) improved the functions of bone marrow-derived dendritic cells (BMDCs) loaded with antigen
Weiwei Li et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Molecular pathways and targets in cancer-related inflammation
Alberto Mantovani et al.
ANNALS OF MEDICINE (2010)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
C Blank et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The biology of the opioid growth factor receptor (OGFr)
IS Zagon et al.
BRAIN RESEARCH REVIEWS (2002)
Expression of HLA class II in colorectal cancer: Evidence for enhanced immunogenicity of microsatellite-instability-positive tumours
SA Bustin et al.
TUMOR BIOLOGY (2001)
Share Paper
